SCHEMBL4215044

SCHEMBL4215044

CCn1nccc1NC(=O)c1cc(F)c(C)c(B2OC(C)(C)C(C)(C)O2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 7/20 0.42
PIK3CA P42336 2/20 0.39
UCHL1 P09936 1/20 0.39
MAPK13 O15264 4/20 0.38
MAPK12 P53778 4/20 0.38
MAPK11 Q15759 4/20 0.38
CXCR2 P25025 4/20 0.36
RAB9A P51151 2/20 0.36
NPC1 O15118 1/20 0.36
P2RY14 Q15391 1/20 0.35
DPP4 P27487 1/20 0.35
DPP8 Q6V1X1 1/20 0.35
DPP9 Q86TI2 1/20 0.35
KLKB1 P03952 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2214493 0.87 MAPK14 (0.40) MAPK14UCHL1CXCR2KMT2A
SCHEMBL396898 0.85 MAPK14 (0.49) MAPK14PIK3CAUCHL1MAPK13MAPK12
SCHEMBL4231887 0.80 MAPK14 (0.49) MAPK14PIK3CAMAPK13MAPK12MAPK11
SCHEMBL2215153 0.77 HDAC6 (0.41) MAPK14UCHL1CXCR2MEN1KMT2A
SCHEMBL4225203 0.76 SIRT2 (0.38) MAPK14PIK3CACXCR2
SCHEMBL14077643 0.75 SMN1; SMN2 (0.47) MAPK14RAB9ANPC1MEN1KMT2A
SCHEMBL13948889 0.74 LIPE (0.36) CXCR2RAB9ANPC1
SCHEMBL601557 0.73 UCHL1 (0.44) UCHL1NPC1MEN1KMT2AALDH1A1
SCHEMBL20460581 0.73 HDAC6 (0.39) MAPK14CXCR2MEN1KMT2ASMN1; SMN2
SCHEMBL20448590 0.71 HDAC1 (0.37) CXCR2RAB9ADPP4SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090023725-A1 Fused Heteroaryl Derivatives for Use as P38 Kinase Inhibitors SMITHKLINE BEECHAM CORPORATION 2009-01-22 US disclosed
US-20090023725-A1 Fused Heteroaryl Derivatives for Use as P38 Kinase Inhibitors SMITHKLINE BEECHAM CORPORATION 2009-01-22 US disclosed
US-20090023725-A1 Fused Heteroaryl Derivatives for Use as P38 Kinase Inhibitors SMITHKLINE BEECHAM CORPORATION 2009-01-22 US disclosed
EP-1708996-B1 FUSED HETEROYRAL DERIVATIVES FOR USE AS P38 KINASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2008-08-27 EP disclosed
EP-1569039-B1 Polymeric charge transport compositions for organophotoreceptors SAMSUNG ELECTRONICS CO LTD (KR) 2008-08-06 EP disclosed
US-7291431-B2 Organophotoreceptor with charge transport compound having an epoxy group SAMSUNG ELECTRONICS CO., LTD. (KR) 2007-11-06 US disclosed
EP-1530096-B1 Organophotoreceptor with a hydrazone polymer charge transport material SAMSUNG ELECTRONICS CO LTD (KR) 2007-06-20 EP disclosed
EP-1418469-B1 Organophotoreceptor with charge transport compound with hydrazone groups SAMSUNG ELECTRONICS CO LTD (KR) 2007-04-04 EP disclosed
US-7166400-B2 Organophotoreceptor with a hydrazone polymer charge transport material SAMSUNG ELECTRONICS CO., LTD. (KR) 2007-01-23 US disclosed
EP-1465020-B1 Organophotoreceptor with a charge transport compound having an epoxy group SAMSUNG ELECTRONICS CO LTD (KR) 2006-10-18 EP disclosed
US-6835514-B2 Flexible photoreceptors for electrophotography SAMSUNG ELECTRONICS CO., LTD. (KR) 2004-12-28 US disclosed
US-6835513-B2 An organophotoreceptor comprising: (a) a charge transport compound having the formula carbazole compound dispersion of colorant particles in an organic liquid and charge transport compound having the formula of carbazole compound SAMSUNG ELECTRONIC CO., LTD. (KR) 2004-12-28 US disclosed
EP-1465020-A2 Organophotoreceptor with a charge transport compound having an epoxy group Samsung Electronics Co., Ltd. (KR) 2004-10-06 EP disclosed
US-20040161685-A1 Organophotoreceptor with a charge transport compound having an epoxy group S-PRINTING SOLUTION CO., LTD. (KR) 2004-08-19 US disclosed
US-20040106054-A1 Organophotoreceptor with charge transport compound with hydrazone groups S-PRINTING SOLUTION CO., LTD. (KR) 2004-06-03 US disclosed
EP-1420303-A2 Organophotoreceptor with charge transport compound having an epoxy group Samsung Electronics Co., Ltd. (KR) 2004-05-19 EP disclosed
EP-1418469-A2 Organophotoreceptor with charge transport compound with hydrazone groups Samsung Electronics Co., Ltd. (KR) 2004-05-12 EP disclosed
US-20040081903-A1 Organophotoreceptor with charge transport compound having an epoxy group HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2004-04-29 US disclosed
US-20030215728-A1 Hydrazone-based charge transport compounds S-PRINTING SOLUTION CO., LTD. (KR) 2003-11-20 US disclosed
US-20030207188-A1 Carbazole based charge transport compounds S-PRINTING SOLUTION CO., LTD. (KR) 2003-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030207188-A1 Carbazole based charge transport compounds SLC33A1, SLC43A1, AHR MAPK14 2210/4885PIK3CA 2910/4885UCHL1 4529/4885
US-20090023725-A1 Fused Heteroaryl Derivatives for Use as P38 Kinase Inhibitors MAPK1, MAPKAPK2, MAPK7 MAPK14 19/4885PIK3CA 1271/4885UCHL1 4310/4885
US-20040081903-A1 Organophotoreceptor with charge transport compound having an epoxy group SLC43A1, SLC46A1, SLC1A2 MAPK14 4002/4885PIK3CA 4118/4885UCHL1 4601/4885
US-20030215728-A1 Hydrazone-based charge transport compounds SLC9A1, SLC9A2, SLC26A4 MAPK14 1676/4885PIK3CA 2461/4885UCHL1 4797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.